Abstract: Three new series of chromene molecules have been synthesized in order to explore their antimicrobial activity. The series encompass 2-substituted 14-(4-halophenyl)-12-methoxy
Introduction
The development of antimicrobial agents is an area of great activity due to the emergence of multidrug resistance in common pathogens and the appearance of new infections. Infectious diseases are considered the second-leading cause of death worldwide; consequently, tremendous efforts have been made to develop new antimicrobial agents that are active especially against the drug resistant strains.
The majority of antimicrobial agents are diverse five-and six-membered heterocyclic molecules that play a crucial role in the metabolism of all living cells [1] . Moreover, a great deal of interest has been directed toward condensed ring systems due to their various types of physiological activities and the success in utilizing them as privileged medicinal scaffolds. In particular, fused chromene and benzochromene molecules have become some of the best potential candidates for pharmacological purposes due to their antimicrobial [2, 3] , antileishmanial [4, 5] , anticancer [6, 7] , antiproliferative [8] , antioxidant [9, 10] , hypertensive [11] , antitumor [12] [13] [14] [15] effects and activities, as well as for the treatment of Alzheimer's disease [16] and schizophrenia disorders [17] .
Fused chromene ring systems also displayed blood platelet antiaggregating [18] , antihistaminic [19] , analgesic [20] [21] [22] , hypolipidemic [23] , DNA breaking and mutagenicity activities [24] . Furthermore, several reports have shown that 7H-benzo[h]chromeno [2,3-d] pyrimidine and 14H-benzo [h] chromeno [3,2-e] [1, 2, 4] triazolo [1,5-c] pyrimidine moieties are promising and attractive scaffolds for the development of potent antimicrobial agents [4, [25] [26] [27] [28] . In addition, 7H-benzo[h]-chromeno [2,3-d] pyrimidine derivatives exhibit anticancer activities [29] [30] [31] [32] [33] .
In continuation of the previous works [15, [25] [26] [27] [28] [29] [30] [31] [34] [35] [36] [37] , it seemed interesting to synthesize some new 7H-benzo[h]chromeno [2,3- [1,5-c] pyrimidine derivatives and to appraise their antimicrobial activities. The structureactivity relationships (SAR) are discussed in this work to correlate between the substituent effects and the activities that aid in drug design.
Results and Discussion

Chemistry
The first series of the new chromene compounds was synthesized via multi component reactions of 4-methoxy-1-naphthol (1) with 4-halobenzaldehydes 2a-c and malononitrile (3) in ethanolic piperidine solution. The solution was refluxed for 1 h and gave the corresponding 2-amino-4-(4-halophenyl)-6-methoxy-4H-benzo[h]chromene-3-carbonitriles 4a-c. The desired compounds were also obtained from the same precursors using microwave irradiation for 2 min. at 140 • C. These results are depicted in Scheme 1. antioxidant [9, 10] , hypertensive [11] , antitumor [12] [13] [14] [15] effects and activities, as well as for the treatment of Alzheimer's disease [16] and schizophrenia disorders [17] . Fused chromene ring systems also displayed blood platelet antiaggregating [18] , antihistaminic [19] , analgesic [20] [21] [22] , hypolipidemic [23] , DNA breaking and mutagenicity activities [24] . Furthermore, several reports have shown that 7H-benzo[h]chromeno [2,3-d] pyrimidine and 14H-benzo[h]chromeno [3,2-e] [1, 2, 4] triazolo [1,5-c] pyrimidine moieties are promising and attractive scaffolds for the development of potent antimicrobial agents [4, [25] [26] [27] [28] . In addition, 7H-benzo[h]-chromeno [2,3-d] pyrimidine derivatives exhibit anticancer activities [29] [30] [31] [32] [33] .
Results and Discussion
Chemistry
The first series of the new chromene compounds was synthesized via multi component reactions of 4-methoxy-1-naphthol (1) with 4-halobenzaldehydes 2a-c and malononitrile (3) in ethanolic piperidine solution. The solution was refluxed for 1 h and gave the corresponding 2-amino-4-(4-halophenyl)-6-methoxy-4H-benzo[h]chromene-3-carbonitriles 4a-c. The desired compounds were also obtained from the same precursors using microwave irradiation for 2 min. at 140 °C. These results are depicted in Scheme 1. Treatment of compounds 4a-c with triethyl orthoformate in acetic anhydride at reflux gave the 2-ethoxymethyleneamino-4-(4-halophenyl)-6-methoxy-4H-benzo[h]chromene-3-carbonitriles 5a-c. Subsequent hydrazinolysis of the latter in ethanol under stirring at room temperature gave 9-amino-
The aminoimino compounds 6 proved to be useful intermediates for the synthesis of a variety of 2-substituted 14H-benzo[h]chromeno [3,2- [1,5-c] pyrimidines 7a-c, whilst acylation of compounds 6a-c with acetyl chloride or acetic anhydride gave the pentacyclic 2-methyltriazolopyrimidine derivatives 7d-f. On the other hand, condensation of compounds 6a-c with diethyl oxalate and ethyl cyanoacetate afforded 2-ethoxycarbonyltriazolopyrimidines 7g-i and 2-cyanomethyltriazolopyrimidine derivatives 7j-l, respectively, as shown in Scheme 3.
Treatment of compounds 4a-c with triethyl orthoformate in acetic anhydride at reflux gave the 2-ethoxymethyleneamino-4-(4-halophenyl)-6-methoxy-4H-benzo[h]chromene-3-carbonitriles 5a-c. Subsequent hydrazinolysis of the latter in ethanol under stirring at room temperature gave 9-amino-7-(4-halophenyl)-5-methoxy-8-imino-7H-benzo[h]chromeno [2,3- 13 C-NMR and MS data. The 7-position of compounds 8 and the 14-position of compounds 7 and 12 are chiral centers, and all the reactions were monitored using the TLC technique. are chiral centers, and all the reactions were monitored using the TLC technique. 
Antibacterial Evaluation
The target compounds 7a-o, 8a-c and 12a-c were tested in vitro for their antimicrobial activities by the agar diffusion method using Mueller-Hinton agar medium for bacteria and Sabouraud's agar medium for fungi [32, 33] . The tested microorganisms were obtained from the Regional Center for Mycology & Biotechnology (RCMP), Al-Azhar University.
The assayed collection included four Gram-positive species of pathogenic bacteria: Staphylococcus aureus (RCMB 000106), Staphylococcus epidermidis (RCMB 000107), Bacillis subtilis (RCMB 000108), Bacillus pumilus (RCMB 000109), and two Gram-negative ones: Pseudomonas aeruginosa (RCMB 000102), Escherichia coli (RCMB 000103), using two standard antibiotics, ampicillin, and streptomycin (25 µg/mL) as reference drugs, and three fungi: Aspergillus fumigatus (RCMB 002003), Candida albicans (RCMB 005002) and Saccharomyces cerevisiae (RCMB 006002), using two standard antibiotics, mycostatine and clotrimazole (25 µg/mL) as reference drugs. The mean zone of inhibition in mm ± standard deviation beyond the well diameter (6 mm) was determined using a 25 µg/mL concentration of the tested compounds. The inhibitory effects of the synthetic compounds against these organisms are given in Figures 1-3 and Table 1 . 
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SAR Studies
The structure activity relationship (SAR) studies of compounds 7a-o, 8a-c and 12a-c revealed that compounds 8a-c and 7j with inhibitory effects of 21.8 ± 0.14, 24.6 ± 0.21, 26.6 ± 0.13 and 27.3 ± 0.47 µg/mL were 1.3, 1.1, 1.0, 1.0 times more active than the standard antibiotic ampicillin (27.4 ± 0.15 µg/mL), while compounds 8a, b were 1.2 and 1.0 times more active than the standard antibiotic streptomycin (25.1 ± 0.18 µg/mL) against S. aureus, respectively, and other compounds showed almost equipotent activities or were inactive, implying that the 7H-benzo Compounds 7a,i,h,g,m,b,n,d,o, 8a, 7c,e,f,j,  8b, 7k ,l, 8c were found to be the most potent against S. epidermidis, with inhibitory effects ranging from 11.9 to 28.5 µg/mL compared to standard antibiotics ampicillin and streptomycin (28.6 ± 0.5 and 29.1 ± 0.3 µg/mL), suggesting that the 14H-benzo 3 µg/mL, respectively, are more effective against S. cerevisiae as compared to the standard antibiotic mycostatine (24.1 ± 0.3 µg/mL) and compounds 8a,b and 7l (16.8-18 .2 µg/mL) are more active than the standard antibiotic clotrimazole (18.3 ± 0.1 µg/mL). The rest of the compounds showed almost equipotent and moderate activities or were inactive.
Experimental Section
General Information
Commercial-grade solvents and reagents were purchased from Sigma-Aldrich (St. Louis, MO, USA) and used without further purification. Melting points were measured with a Stuart Scientific (Stone, Staffordshire, UK) apparatus and are uncorrected. IR spectra were determined as KBr pellets on a Jasco FT/IR 460 plus spectrophotometer (Jasco, Tokoyo, Japan). 1 H-NMR (500 MHz) and 13 C-NMR (125 MHz) spectra were recorded using a Bruker AV 500 MHz spectrometer (Bruker, Billerica, MA, USA). Chemical shifts (δ) are expressed in parts per million (ppm). The 1 H-NMR and 13 C-NMR spectra of the compounds are provided in the Supplementary Material. The MS were measured using a Shimadzu GC/MS-QP5050A spectrometer (Shimadzu, Tokoyo, Japan). Elemental analyses were carried out at the Regional Centre for Mycology & Biotechnology (RCMP, Al-Azhar University, Cairo, Egypt) and the results were within ±0.3% of calculated values. Analytical thin layer chromatography (TLC) on silica gel precoated F 254 plates (Merck, Billerica, MA, USA) was used to check the purity of the final compounds and intermediates. [34] [35] [36] [37] , [29] [30] [31] and [29] [30] [31] , respectively).
Synthesis
General Procedure for the Synthesis of Compounds 7a-c
A mixture of aminoimino compound 6a-c (3.88, 4.04, or 4.49 g, respectively, 0.01 mol) and formic acid or methyl formate (0.46 g or 0.6 g, 0.01 mol) in dry benzene (30 mL) was refluxed for 5 h. The solvent was extracted and the resulting products were recrystallized from ethanol/1,4-dioxane to give 7a-c. The physical data of the compounds 7a-c are as follows: 
General Procedure for the Preparation of Compounds 7d-f
A mixture of aminoimino compounds 6a-c (3.88, 4.04, or 4.49 g, respectively, 0.01 mol) and acetyl chloride or acetic anhydride (30 mL) was refluxed for 2 h. The solvent was extracted and the resulting product was recrystallized from 1,4-dioxan to give 7d-f. The physical data of the compounds 7d-f are as follows: 
